EWTX - Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Logo

EWTX - Edgewise Therapeutics Inc

https://edgewisetx.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Neutral
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Aytu BioPharma ( NASDAQ:AYTU ) , Circle Internet Group ( NYSE:CRCL )
Benzinga • 2 months, 2 weeks ago • score: 0.14
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Ascendiant Capital analyst Edward Woo initiated coverage on Aytu BioPharma, Inc.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.

52W High
$38.12
52W Low
$10.60
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.27
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.60
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
2.78
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.44%
Institutions (25–75% balanced)
116.36%
Shares Outstanding
105,346,000
Float
60,534,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-1.56
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.27%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.3744
Previous
0.2790
Trend
Rising
Signal Cross
No cross
As of
Sep. 05, 2025